The endogenous NOS inhibitor asymmetric dimethylarginine (ADMA) predicts LV mass independent of afterload
A.L. Sverdlov, D.T.M. Ngo, A.K. Nightingale, S. Rajendran, K. Mishra, T. Heresztyn, R.H. Ritchie, T.H. Marwick, M.P. Frenneaux, J.D. HorowitzVolume:
25
Year:
2011
Language:
english
DOI:
10.1016/j.niox.2011.04.009
File:
PDF, 552 KB
english, 2011